ABSTRACT Two experiments were carried out to evaluate the effect of using soy protein concentrate (SPC) in pre-starter and starter diets for broilers. In the first experiment, 600 male Cobb broilers, between one and 40 days of age, were distributed in a completely randomized design, with four treatments and six replications of 25 birds each. Treatments were ofered to broilers in the pre-starter and starter diets and consisted of inclusion of soy protein concentrate (0,3,6 and 9%) in diets. The parameters evaluated were: body weight gain, feed conversion ratio, consumption of ration, enzyme production in the pancreas, villus: crypt ratio, leukocyte count and immunoglobulin A (IgA) dosage. Aimed to determine the coefficient of nutrient metabolization of feeds, 144 male Cobb chicks were distributed, between 14 and 21 days of age, with four treatments and six replications of six birds per experimental unit. Treatments were the same as in the first experiment. The use of 3 and 9% of SPC did not affect weight gain, feed intake, feed conversion or viability of the poultry. The use of 6% of SPC provided an increase in trypsin activity, villi length and crypt depth; the coefficient of dry matter metabolization increased linearly; but no differences were observed in performance or immunological parameters.

Abstract: Acute myocardial infarction is a sudden illness, its development is unique to each person, and is influenced by socio demographic conditions. The aim of this work was to develop an epidemiological profile of patients who were discharged in a tertiary hospital in Mexico between of years of 2008 to the 2013 and identify the type of treatment and outcome of improving health. A descriptive retrospective study was performed, obtaining information from medical records. Of the total number of people served (325), 46% have overcome illness, more often in men (85.4%), average age 59 years. 92% had their first acute event, 43.7% reported a factor associated with cardiovascular disease, hypertension (57%) and type II diabetes (39%) are co-morbidities. In surgery as a treatment an association was found in the days of hospital stay and a trend to complications, suggesting surgical evaluation protocol election.

Resumen: El infarto agudo al miocardio es una enfermedad súbita; su desarrollo es particular en cada persona, y se ve influenciado por condiciones sociodemográficas y rasgos de la afección. El objetivo de este trabajo fue elaborar un perfil epidemiológico de pacientes con diagnóstico de infarto que fueron dados de alta de un hospital de tercer nivel en México, entre el 2008 y el 2013, e identificar el tipo de tratamiento y evolución de la mejora de salud. Se realizó un estudio descriptivo retrospectivo, obteniendo la información de los expedientes clínicos. Del total de personas atendidas (325), sobrevivieron el 46%, con mayor frecuencia en hombres (85.4%); la edad promedio fue de 59 años. El 92% presentaba su primer evento agudo, el 43.7% reportó un factor asociado a enfermedad cardiovascular, siendo la hipertensión arterial (57%) y la diabetes tipo II (39%) co-morbilidades. En la cirugía como tratamiento se encontró asociación en los días de estancia hospitalaria y una tendencia a complicaciones, sugiriendo evaluación en protocolo de elección quirúrgica.

Abstract Conventional bacteriology techniques and quantitative polymerase-chain reaction (qPCR) were applied to the eggshell, albumen, and yolk of washed and unwashed commercial white and brown eggs, to detect Salmonella spp. Pooled samples of eggshells, albumen, and yolk of white and brown eggs were collected at the poultry house and at the egg-storage room. Salmonella spp. was detected by conventional bacteriology in 5.4% (21/387) of analyzed samples and in 16% (68/387) by qPCR. In the 114 unwashed white eggs samples of eggshell, albumen and yolk, the bacterium was identified in 2.6% of the eggs (3/114) by conventional bacteriology and in 13.2% (15/114) by qPCR. In the 90 samples of washed eggs, 6.7% (6/90) were contaminated as detected by conventional bacteriology and 10.0% (9/90) by qPCR. In the 81 samples of unwashed brown eggs, Salmonella spp. was detected in 6.1% of the eggs (5/81) by conventional bacteriology and 27.2% (22/81) by qPCR. In the 102 samples of brown washed eggs, 6.9% (7/102) where positive by conventional bacteriology and 35.3% (16/102) by qPCR. All samples detected as positive by conventional bacteriology were also positive by qPCR. Salmonella Agona represented 18.2% (4/22) of identified serovars, Salmonella enterica subs. enterica O: 4.5 18.2% (4/22), Salmonella Schwarzengrund 18.2% (4/22), Salmonella Cerro 13.6% (3/22), Salmonella Anatum 13.6% (3/22), Salmonella Enteritidis 9.1% (2/22), Salmonella Johannesburg 4.5% (1/22), and Salmonella Corvallis 4.5% (1/22). The qPCR method provided better detection of Salmonella spp. in commercial eggs than conventional bacteriology. The conventional egg washing and disinfection procedures are not efficient to eliminate Salmonella.

ABSTRACTAn experiment was conducted to evaluate the performance and nutrient metabolizability of broilers fed diets containing fumonisin B1 (FB1) and an esterified glucomannan (EGM). In total, 420 male broilers were distributed according to a 3 x 2 + 1 factorial arrangement, corresponding to three FB1 exposure times (seven, 21, or 35 days), two dietary glucomannan addition levels (0 or 0.1% EGM), and control diet, totaling seven treatments. The following diets were fed: 1) Control diet, 2) pre-starter diet containing FB1, 3) pre-starter diet containing FB1 and 0.1% EGM, 4) starter diet containing FB1, 5) starter diet containing FB1 and 0.1% EGM, 6) grower diet containing FB1, and 7) grower diet containing FB1 and 0.1% EGM. On d 7, broilers fed FB1 presented lower body weight gain and feed intake (p<0.05) compared with control treatment. On d 21, no significant performance differences were detected among treatment groups (p>0.05). At 35 days of exposure to FB1 body weight gain was reduced (p<0.05) compared with broilers fed fumonisin B1 for seven days. From 4 to 7 days and 18 to 21 days of age, FB1 reduced nutrient metabolizability (p<0.05). From 36 to 39 days of age, the EGM allowed maintaining apparent metabolizability for ether extract. It was concluded that the EGM did not reduce FB1 effects on performance or nutrient metabolizability in broilers, except for apparent metabolizability of ether extract.

The aim of this study was to evaluate the performance, tibial density and mineral content, Na, K ,and Cl serum levels, and dry matter content of the litter of broilers fed diets with different levels of dietary electrolyte balances. Two experiments were carried out: during the starter phase (7 to 21 days of age, 960 broilers) and during the growe phase (22 to 38 days of age, 816 broilers). In both experiments, a completely randomized design with four treatments based on dietary electrolyte balance values (200, 240, 280 and 320 mEq/kg of diet) with four replicates was applied. Birds and diets were weighed when birds were seven, 14 and 21 days of age in the first experiment, and 22 and 38 days of age in the second experiment in order to determine weight gain, feed intake and feed conversion. Final body weight, weight gain, feed intake and feed conversion and mortality rate were evaluated. On days 21 and 38, the left tibia of two birds per replicate was collected to determine bone density and the serum was used for Na and K analysis. Litter dry matter content was also determined on days 21 and 38 . There was no effect of dietary electrolyte balance values on broilers performance between 7 and 14, 7 and 21, or 22 and 38 days of age, tibial bone density and mineral content, or on Na, K and Cl serum levels. Litter dry matter was linearly reduced as dietary electrolyte balance value increased. Diets with 200 mEq/kg may be recommended for broilers from 7 to 38 days of age with no negative influence on the evaluated parameters.